Servier Laboratories News Today

Shared lab spaces provide a streamlined launchpad, offering benches as well as a diverse network of industry mentors. Shared lab spaces provide a streamlined launchpad, offering benches as well as a diverse network of industry mentors.

France's Servier laboratories group, which marketed Mediator – a drug used as an appetite suppressant and accused of causing serious cardiovascular damage – has been fined more than €7 million on appeal…

Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The

Promising results in a trial of ketamine for severe depression could lead to treatment becoming more affordable in Australia.

The oral drug vorasidenib nearly tripled progression-free survival in patients with grade 2 gliomas compared to placebo, nearly 28 months versus 11 months, according to a recent study.

A new experimental drug therapy has shown some promising signs of slowing down the progression of a type ...

MONDAY, June 5, 2023 (HealthDay News) -- An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.

Alice Reiner, a director at MSD, moved to Switzerland in 2020 with her husband and daughter

The manufacturer of this antidiabetic drug was found guilty of aggravated deceit and involuntary manslaughter but acquitted of fraud and improperly obtained marketing authorization.

The company was fined 2.7 million euros ($2.88 million) for concealing Mediator's risks, and ordered to pay more than 180 million euros in compensation and interest to victims. Servier is appealing more than half a dozen convictions against the company and former head of operations Jean-Philippe Seta, including for manslaughter with wilful misconduct, involuntary injury, fraud and deception.